ArticleArchives of microbiology2026
Evaluation of a recombinant Loa22-gold nanoparticle based lateral flow assay for the serodiagnosis of leptospirosis in canine and bovine.
Article in Archives of microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A recombinant Loa22-based latex agglutination test and indirect ELISA for the sero-detection of leptospirosis in dogs and cattle.Archives of microbiology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Leptospirosis is a globally significant zoonotic disease caused by the pathogenic Leptospira spp. This study aimed to develop a recombinant Loa22 based lateral flow assay for detecting leptospirosis in dogs and cattle. The loa22 gene from Leptospira interrogans was cloned, expressed in E. coli, and purified using Ni-NTA affinity chromatography. The immunoreactivity of the recombinant protein was confirmed by western blotting, and hyperimmune sera against the protein was raised in mice. Gold nanoparticles (AuNP) were conjugated with rLoa22 under optimized conditions and characterized by UV-Vis spectrophotometry, agarose gel electrophoresis, and transmission electron microscopy. The lateral flow assay (LFA) strips were assembled with AuNP-rLoa22 on the conjugate pad and rLoa22 and hyperimmune sera on the test and control lines, respectively. Diagnostic performance of the assay was evaluated using sera from 100 dogs and 102 cattle suspected for leptospirosis and compared to the reference standard microscopic agglutination test (MAT). Six dog and cattle samples each were tested positive by MAT. The developed LFA further tested 06 dog and 07 cattle samples as positive in addition to the MAT positive samples, representing false positives. In dogs, the LFA showed 100% sensitivity and 93.62% specificity, while in cattle, it showed 100% sensitivity (Se) and 92.71% specificity (Sp) with respect to MAT. The n/N for Se and Sp were, Se
Indexed as
Identifiers
41524783What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.